Sobi and Sanofi's Foundation S extend partnership with the World Federation of Hemophilia Humanitarian Aid Program
STOCKHOLM, April 25, 2025, 00:23 GMT-04
SwedishOrphanBiovitru
Read full article →
Category
Healthcare
This category brings together content related to healthcare, medicine, clinical research, healthcare services, medical devices, therapies and the development of solutions for the sector. Sector classification by EMSF Lisboa.
Sanofi and Sobi extend their partnership with the World Federation of Hemophilia Humanitarian Aid Program
MONTREAL, April 25, 2025, 00:01 GMT-04
World-Federation
Read full article →
Keymed Biosciences Announces Approval of IND for CM518D1 by the National Medical Products Administration of China for the Treatment of Gastrointestinal Cancers
CHENGDU, China, April 25, 2025, 23:50 GMT-04
Keymed-IND
Read full article →
A Success Story - DelveInsight's Strategic Support to a Biopharma Leader in NSCLC Epidemiology Forecasting up to 2034, Segmented by Biomarker Types
LAS VEGAS, April 24, 2025, 17:46 GMT-04
DELVEINSIGHT-Biopharm
Read full article →
IBRANCE's Market Growth Marks a Significant Step Forward in Metastatic HR+/HER2− Breast Cancer Treatment Landscape | DelveInsight
LAS VEGAS, April 24, 2025, 17:31 GMT-04
DelveInsight-Business
Read full article →
At-Home Genetic Testing Market to Reach $4.5 Bn By 2027 in the short run and $20.2 Bn By 2035 Globally, at 20.3% CAGR: Allied Market Research
WILMINGTON, Del., April 24, 2025, 10:01 GMT-04
ALLIEDMARKETRESEARCH
Read full article →
Abu Dhabi Pioneers Collaborative Approach to Responsible AI in Healthcare at Health Leaders Roundtable
ABU DHABI, UAE, April 24, 2025, 09:18 GMT-04
Abu-Dhabi-Health-AI
Read full article →
Endo's New Spatial Computing Injection Simulator for Peyronie's Disease Creates Immersive Learning Environment for Urology Specialists
MALVERN, Pa., April 24, 2025, 07:15 GMT-04
Endo-SpatialInjection
Read full article →
PFAS Filtration Market worth $2.99 billion by 2030 - Exclusive Report by MarketsandMarkets™
DELRAY BEACH, Fla., April 24, 2025, 06:45 GMT-04
MarketsandMarkets
Read full article →
Novo Holdings and EIFO invest €48 million in HealthCap IX to strengthen the Nordic life sciences ecosystem
COPENHAGEN, Denmark, April 24, 2025, 05:00 GMT-04
NOVO-HealthCap
Read full article →
OMRON Healthcare Donates 4,000 Blood Pressure Monitors and Advances AFib Screening with AI-based Intellisense AFib Technology
KYOTO, Japan, April 24, 2025, 04:00 GMT-04
OMRON-CAMPAIGN
Read full article →
Sun Pharma and Moebius Medical Announce Dual Publications on MM-II's Phase 2b Clinical Trial Results and Mechanism of Action in Osteoarthritis and Cartilage
MUMBAI, India and TEL AVIV, Israel, April 24, 2025, 02:31 GMT-04
Moebius-SUN-Pharma
Read full article →
Metastatic Colorectal Cancer Market Poised for Expansion Across the 7MM During the Forecast Period (2025-2034) as Breakthrough Therapies Gain Traction | DelveInsight
LAS VEGAS, April 23, 2025, 17:31 GMT-04
DELVEINSIGHT
Read full article →
Implantica opens a new RefluxStop™ center in a new region of Spain, addressing the fast-growing demand
VADUZ, Liechtenstein, April 23, 2025, 02:13 GMT-04
Implantica
Read full article →
Investment of Approx. USD 4.5 Million in Development of Diagnostics for Tuberculosis to Partners Including Fujirebio and University Hospital Heidelberg
TOKYO, April 23, 2025, 21:00 GMT-04
GHITFund
Read full article →
XADAGO/EQUFINA Set to Revolutionize Parkinson's Disease Treatment Landscape | DelveInsight
LAS VEGAS, April 22, 2025, 17:31 GMT-04
DelveInsight-Business
Read full article →
Veterinary Poc Hematology Diagnostics Market to Reach $1.7 Bn by 2027 in the short run and $2.3 Bn by 2030 Globally, at 9.3% CAGR: Allied Market Research
WILMINGTON, Del., April 22, 2025, 10:01 GMT-04
AMR
Read full article →
Tagworks Pharmaceuticals Announces FDA Clearance of IND Application and Initiation of Phase 1 Clinical Trial for TGW101 and Appoints Keith Orford, MD, PhD, as Chief Medical Officer
NIJMEGEN, Netherlands and BOSTON, April 22, 2025, 07:00 GMT-04
Tagworks-Pharma-FDA
Read full article →
Overcoming the Limits of Injectables: SYNERJET PRO™ Enters Pre-Market Stage in Russia to Deliver Smarter Solutions for Safety-Conscious Patients
SEOUL, South Korea, April 22, 2025, 03:00 GMT-04
HIRONIC
Read full article →
Onward Therapeutics Announces IMPD Approval for Its Subsidiary Emercell to Start Clinical Investigation of Allogeneic NK Cell Therapy OT-C001 in Combination with Rituximab
EPALINGES, Switzerland and PARIS, April 22, 2025, 02:00 GMT-04
Onward-Therapeutics
Read full article →